---
category: listing
circular_id: 6fed967b5672e130
date: '2025-09-02'
description: NSE announces listing of additional equity shares issued under ESOP/ESOS
  schemes for 18 companies effective September 3, 2025
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML69975.pdf
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine ESOP/ESOS allotments with minimal market impact as shares are
  already trading
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML69975.pdf
processing:
  attempts: 1
  content_hash: d87510284a23d33e
  processed_at: '2025-09-02T15:52:49.150962'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-09-02T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML69975.pdf
severity: low
source: nse
stocks:
- AXISBANK
- BLACKBUCK
- BLISSGVS
- CLEAN
- CREDITACC
- DCBBANK
- GODIGIT
- INDIGO
- ITCHOTELS
- JAGSNPHARM
- MANYAVAR
- MAXESTATES
- NACLIND
- PEARLGLOB
- POLYCAB
- RSYSTEMS
- TCIEXP
- TRACXN
tags:
- capital-market
- equity
- esop
title: Listing of further issues of securities - ESOP/ESOS
---

## Summary

The National Stock Exchange has notified the listing of additional equity shares issued under Employee Stock Option Plans (ESOP) and Employee Stock Ownership Schemes (ESOS) for 18 companies. These securities will be admitted to dealings on the NSE Capital Market segment effective September 3, 2025, with standard market lot size of 1 share for all listed securities.

## Key Points

- 18 companies issuing additional shares under ESOP/ESOS schemes
- All securities to be listed on September 3, 2025
- Market lot size standardized at 1 share for all securities
- All shares are pari passu with existing equity shares
- Lock-in period applicable only for Bliss GVS Pharma shares (until January 28, 2026)

## Regulatory Changes

No regulatory changes announced. This circular follows standard procedures under Regulation 3.1.1 and Regulation 2.5.5 of the National Stock Exchange (Capital Market) Trading Regulations Part A.

## Compliance Requirements

- Companies must ensure proper identification of securities using designated security codes
- Trading must be conducted in specified lot sizes (1 share for all securities)
- Members must note the effective date of September 3, 2025 for trading commencement

## Important Dates

- **Circular Date**: September 2, 2025
- **Effective Date**: September 3, 2025
- **Lock-in Expiry (Bliss GVS Pharma only)**: January 28, 2026

## Impact Assessment

Minimal market impact expected as these are routine ESOP/ESOS allotments representing small additions to existing share capital. The shares are pari passu with existing equity, ensuring no dilution of rights for current shareholders. The standardized lot size of 1 share ensures maximum liquidity and accessibility for all market participants.